within Pharmacolibrary.Drugs.ATC.R;

model R02AA16
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R02AA16</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Benzalkonium is a quaternary ammonium compound used as a disinfectant and antiseptic. It is used in various topical formulations, such as throat lozenges and sprays, eye drops, and as a preservative in nasal sprays and ophthalmic solutions. It is not typically used systemically and does not have systemic therapeutic indications; its use is mainly for local antiseptic effects. It is not approved for systemic use.</p><h4>Pharmacokinetics</h4><p>No systemic pharmacokinetic data available in humans; used locally/topically and not intended for systemic exposure. Parameters estimated based on reference range for quaternary ammonium compounds if any absorption occurs (very low bioavailability).</p><h4>References</h4><ol><li><p>Zhou, T, et al., &amp; Zhang, J (2020). A Comparative Ocular Pharmacokinetics Study of Preservative-Free Latanoprost Unit-Dose Eye Drops and a Benzalkonium Chloride-Preserved Branded Product Following Topical Application to Rabbits. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 36(7) 522–528. DOI:<a href=\"https://doi.org/10.1089/jop.2019.0102\">10.1089/jop.2019.0102</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32310714/\">https://pubmed.ncbi.nlm.nih.gov/32310714</a></p></li><li><p>Rasmussen, CA, et al., &amp; Kiland, JA (2014). Benzalkonium chloride and glaucoma. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 30(2-3) 163–169. DOI:<a href=\"https://doi.org/10.1089/jop.2013.0174\">10.1089/jop.2013.0174</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24205938/\">https://pubmed.ncbi.nlm.nih.gov/24205938</a></p></li><li><p>de Jong, C, et al., &amp; van Best, J (1994). Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma. <i>Graefe&#x27;s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie</i> 232(4) 221–224. DOI:<a href=\"https://doi.org/10.1007/BF00184009\">10.1007/BF00184009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8034210/\">https://pubmed.ncbi.nlm.nih.gov/8034210</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R02AA16;
